[go: up one dir, main page]

SG10201500705YA - Methods and compositions for improving efficiency of nucleic acids amplification reactions - Google Patents

Methods and compositions for improving efficiency of nucleic acids amplification reactions

Info

Publication number
SG10201500705YA
SG10201500705YA SG10201500705YA SG10201500705YA SG10201500705YA SG 10201500705Y A SG10201500705Y A SG 10201500705YA SG 10201500705Y A SG10201500705Y A SG 10201500705YA SG 10201500705Y A SG10201500705Y A SG 10201500705YA SG 10201500705Y A SG10201500705Y A SG 10201500705YA
Authority
SG
Singapore
Prior art keywords
compositions
methods
nucleic acids
amplification reactions
improving efficiency
Prior art date
Application number
SG10201500705YA
Inventor
Xiao-Song Gong
John Sullivan
Rongdian Fu
Yan Wang
Evan H Bursey
Man Cheng
Original Assignee
Bio Rad Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Rad Laboratories filed Critical Bio Rad Laboratories
Publication of SG10201500705YA publication Critical patent/SG10201500705YA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/26Preparation of nitrogen-containing carbohydrates
    • C12P19/28N-glycosides
    • C12P19/30Nucleotides
    • C12P19/34Polynucleotides, e.g. nucleic acids, oligoribonucleotides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/12Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241Nucleotidyltransferases (2.7.7)
    • C12N9/1252DNA-directed DNA polymerase (2.7.7.7), i.e. DNA replicase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6804Nucleic acid analysis using immunogens
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/686Polymerase chain reaction [PCR]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/50Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/50Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565Complementarity determining region [CDR]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/70Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76Antagonist effect on antigen, e.g. neutralization or inhibition of binding
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/80Fusion polypeptide containing a DNA binding domain, e.g. Lacl or Tet-repressor

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
SG10201500705YA 2009-01-08 2010-01-07 Methods and compositions for improving efficiency of nucleic acids amplification reactions SG10201500705YA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14335009P 2009-01-08 2009-01-08

Publications (1)

Publication Number Publication Date
SG10201500705YA true SG10201500705YA (en) 2015-04-29

Family

ID=42316809

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10201500705YA SG10201500705YA (en) 2009-01-08 2010-01-07 Methods and compositions for improving efficiency of nucleic acids amplification reactions
SG2011050093A SG172925A1 (en) 2009-01-08 2010-01-07 Methods and compositions for improving efficiency of nucleic acids amplification reactions

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG2011050093A SG172925A1 (en) 2009-01-08 2010-01-07 Methods and compositions for improving efficiency of nucleic acids amplification reactions

Country Status (7)

Country Link
US (3) US8859205B2 (en)
EP (2) EP2894226B1 (en)
JP (1) JP5818688B2 (en)
CN (1) CN102272319B (en)
CA (1) CA2749093C (en)
SG (2) SG10201500705YA (en)
WO (1) WO2010080910A1 (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9181551B2 (en) 2002-02-20 2015-11-10 Sirna Therapeutics, Inc. RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
US9657294B2 (en) 2002-02-20 2017-05-23 Sirna Therapeutics, Inc. RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
SG10201500705YA (en) * 2009-01-08 2015-04-29 Bio Rad Laboratories Methods and compositions for improving efficiency of nucleic acids amplification reactions
EP2694684B1 (en) * 2011-04-08 2017-05-31 Bio-Rad Laboratories, Inc. Sso7-polymerase conjugates with decreased non-specific activity
WO2012138416A1 (en) 2011-04-08 2012-10-11 Bio-Rad Laboratories, Inc. Pcr reaction mixtures with decreased non-specific activity
US8470573B2 (en) * 2011-06-21 2013-06-25 Bio-Rad Laboratories, Inc. Hybrid polymerases having the ability to produce long amplicons
CN103045554B (en) * 2012-11-29 2014-10-29 成都福际生物技术有限公司 Method for preparing hot start Taq polymerase
CN105247076B (en) * 2013-03-15 2021-06-18 莱尔·J·阿诺德 Methods of Amplifying Fragmented Target Nucleic Acids Using Assembled Sequences
EP2986719B1 (en) 2013-12-06 2020-07-29 Bio-Rad Laboratories, Inc. Fusion polymerases
US9963687B2 (en) 2014-08-27 2018-05-08 New England Biolabs, Inc. Fusion polymerase and method for using the same
CN113584015B (en) * 2014-08-27 2025-05-02 新英格兰生物实验室公司 Synthon formation
US10273530B2 (en) 2016-01-15 2019-04-30 Thermo Fisher Scientific Baltics Uab Antibodies that bind thermophilic DNA polymerases
EP3402880B1 (en) 2016-01-15 2024-01-03 Thermo Fisher Scientific Baltics UAB Thermophilic dna polymerase mutants
EP3645710A1 (en) 2017-06-26 2020-05-06 Thermo Fisher Scientific Baltics Uab Thermophilic dna polymerase mutants
WO2019045532A2 (en) 2017-08-31 2019-03-07 Seegene, Inc. Evaluation of performance of components using a pair of dimer-forming primers
CN112375807B (en) * 2017-12-30 2023-02-21 浙江安诺优达生物科技有限公司 Method for randomly breaking DNA
CN114341150B (en) 2019-06-25 2025-01-14 生物辐射实验室股份有限公司 Compositions and methods for enhancing reverse transcriptase activity and/or reducing reverse transcriptase inhibition
CN115209915A (en) * 2020-01-06 2022-10-18 成对植物服务股份有限公司 Recruitment of DNA polymerase for templated editing
JP2021153393A (en) * 2020-03-25 2021-10-07 東洋紡株式会社 Compositions for nucleic acid amplification reaction
US20250145989A1 (en) * 2022-01-26 2025-05-08 Seegene, Inc. Method for detecting target nucleic acids in sample
WO2025116499A1 (en) * 2023-11-27 2025-06-05 Seegene, Inc. Method for analyzing activity of nucleic acid polymerase using self-dimer primer

Family Cites Families (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CU22545A1 (en) * 1994-11-18 1999-03-31 Centro Inmunologia Molecular OBTAINING A CHEMICAL AND HUMANIZED ANTIBODY AGAINST THE RECEPTOR OF THE EPIDERMAL GROWTH FACTOR FOR DIAGNOSTIC AND THERAPEUTIC USE
US4545985A (en) 1984-01-26 1985-10-08 The United States Of America As Represented By The Secretary, Dept. Of Health And Human Services Pseudomonas exotoxin conjugate immunotoxins
US4751180A (en) 1985-03-28 1988-06-14 Chiron Corporation Expression using fused genes providing for protein product
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US5679543A (en) 1985-08-29 1997-10-21 Genencor International, Inc. DNA sequences, vectors and fusion polypeptides to increase secretion of desired polypeptides from filamentous fungi
US4935233A (en) 1985-12-02 1990-06-19 G. D. Searle And Company Covalently linked polypeptide cell modulators
US6025545A (en) * 1990-01-22 2000-02-15 Dekalb Genetics Corporation Methods and compositions for the production of stably transformed, fertile monocot plants and cells thereof
US5489523A (en) * 1990-12-03 1996-02-06 Stratagene Exonuclease-deficient thermostable Pyrococcus furiosus DNA polymerase I
ES2145004T3 (en) * 1991-08-21 2000-07-01 Novartis Ag DERIVATIVES OF ANTIBODIES.
US5436149A (en) 1993-02-19 1995-07-25 Barnes; Wayne M. Thermostable DNA polymerase with enhanced thermostability and enhanced length and efficiency of primer extension
US5914110A (en) * 1993-09-07 1999-06-22 Smithkline Beecham Corporation Recombinant IL4 antibodies useful in treatment of IL4 mediated disorders
JP3616394B2 (en) * 1994-01-31 2005-02-02 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア Method for removal of DNA sequencing artifacts
US5512462A (en) 1994-02-25 1996-04-30 Hoffmann-La Roche Inc. Methods and reagents for the polymerase chain reaction amplification of long DNA sequences
US5912155A (en) 1994-09-30 1999-06-15 Life Technologies, Inc. Cloned DNA polymerases from Thermotoga neapolitana
US6015668A (en) 1994-09-30 2000-01-18 Life Technologies, Inc. Cloned DNA polymerases from thermotoga and mutants thereof
US5773258A (en) 1995-08-25 1998-06-30 Roche Molecular Systems, Inc. Nucleic acid amplification using a reversibly inactivated thermostable enzyme
JP2000502882A (en) 1995-09-08 2000-03-14 ライフ・テクノロジーズ・インコーポレイテッド Cloned DNA polymerases from Thermotoga and variants thereof
DE69739357D1 (en) * 1996-06-04 2009-05-28 Univ Utah Res Found MONITORING HYBRIDIZATION DURING PCR
US6458556B1 (en) * 1996-07-25 2002-10-01 The Institute Of Physical & Chemical Research Method for enhancing enzyme activity at elevated temperature
JP3206894B2 (en) * 1996-07-25 2001-09-10 理化学研究所 How to heat activate enzymes
US6972323B1 (en) * 1997-04-01 2005-12-06 Sankyo Company, Limited Anti-Fas antibodies
US5882904A (en) 1997-08-04 1999-03-16 Amersham Pharmacia Biotech Inc. Thermococcus barossii DNA polymerase mutants
CN1637146A (en) * 1998-04-23 2005-07-13 宝生物工程株式会社 Method for synthesizing DNA
EP1111044A4 (en) * 1998-09-08 2003-06-04 Takara Shuzo Co DNA SYNTHESIS PROCESS
US20040031072A1 (en) * 1999-05-06 2004-02-12 La Rosa Thomas J. Soy nucleic acid molecules and other molecules associated with transcription plants and uses thereof for plant improvement
JP3589912B2 (en) * 1999-09-03 2004-11-17 泰久 福井 Monoclonal antibody recognizing phosphatidylinositol-3,4-diphosphate
IT1307309B1 (en) * 1999-12-30 2001-10-30 Enea Ente Nuove Tec STABILIZING PEPTIDES, POLYPEPTIDES AND ANTIBODIES THAT INCLUDE THEM.
IL151873A0 (en) * 2000-03-24 2003-04-10 Micromet Ag Multifunctional polypeptides comprising a binding site to an epitope of the nkg2d receptor complex
US6627424B1 (en) 2000-05-26 2003-09-30 Mj Bioworks, Inc. Nucleic acid modifying enzymes
US7408041B2 (en) * 2000-12-08 2008-08-05 Alexion Pharmaceuticals, Inc. Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof
US20040131607A1 (en) * 2001-06-08 2004-07-08 Carroll Michael C. Methods and compositions for inhibiting immunoglobulin-mediated reperfusion injury
EP1275735A1 (en) 2001-07-11 2003-01-15 Roche Diagnostics GmbH Composition and method for hot start nucleic acid amplification
US7365167B2 (en) * 2001-11-26 2008-04-29 Cell Matrix, Inc. Humanized collagen antibodies and related methods
DE60235491D1 (en) 2001-11-28 2010-04-08 Bio Rad Laboratories PARALLEL SCORING OF POLYMORPHISMS WITH AMPLIFICATION AND ERROR CORRECTION
DE60228618D1 (en) 2001-11-28 2008-10-09 Bio Rad Laboratories METHOD FOR USING IMPROVED POLYMERASES
US7560260B2 (en) 2002-07-25 2009-07-14 Bio-Rad Laboratories, Inc. Compositions with polymerase activity
EP2264155A1 (en) * 2002-07-25 2010-12-22 Bio-Rad Laboratories, Inc. Hybrid polymerase methods and compositions
US7666645B2 (en) 2002-10-23 2010-02-23 Bio-Rad Laboratories, Inc. Sso7-polymerase conjugate proteins
US8283148B2 (en) 2002-10-25 2012-10-09 Agilent Technologies, Inc. DNA polymerase compositions for quantitative PCR and methods thereof
JP2006507012A (en) * 2002-10-25 2006-03-02 ストラタジーン カリフォルニア DNA polymerase with reduced base analog detection activity
US7704712B2 (en) 2003-03-25 2010-04-27 Stratagene California DNA polymerase fusions and uses thereof
US20040214194A1 (en) 2003-04-17 2004-10-28 Mj Bioworks, Inc. Methods of making hybrid proteins
US20050025763A1 (en) * 2003-05-08 2005-02-03 Protein Design Laboratories, Inc. Therapeutic use of anti-CS1 antibodies
CA2560945C (en) 2004-04-01 2013-06-18 Bio-Rad Laboratories, Inc. Quantitative amplification with a labeled probe and 3' to 5' exonuclease activity
US20060005174A1 (en) 2004-07-01 2006-01-05 International Business Machines Corporation Defining hierarchical structures with markup languages and reflection
US20060172324A1 (en) * 2005-01-28 2006-08-03 Roche Molecular Systems, Inc. Methods of genotyping using differences in melting temperature
CA2615151A1 (en) * 2005-07-15 2007-01-25 Stratagene California Dna binding protein-polymerase chimeras
AU2006291990B2 (en) * 2005-09-13 2012-05-31 National Research Council Of Canada Methods and compositions for modulating tumor cell activity
JP2009521496A (en) * 2005-12-23 2009-06-04 イーライ リリー アンド カンパニー TGF-β binding composition
EP2097523B1 (en) * 2006-12-29 2014-10-29 Agilent Technologies, Inc. Compositions and methods using split polymerases
PE20081760A1 (en) * 2007-02-09 2009-01-01 Genentech Inc ANTI-THEFT4 ANTIBODIES AND THEIR USES
EP2297343A1 (en) 2008-05-16 2011-03-23 New England Biolabs, Inc. Enzyme reagents for amplification of polynucleotides in the presence of inhibitors
SG10201500705YA (en) * 2009-01-08 2015-04-29 Bio Rad Laboratories Methods and compositions for improving efficiency of nucleic acids amplification reactions

Also Published As

Publication number Publication date
EP2894226B1 (en) 2021-04-14
US9994887B2 (en) 2018-06-12
CA2749093C (en) 2019-03-26
US20110104760A1 (en) 2011-05-05
US20180258455A1 (en) 2018-09-13
SG172925A1 (en) 2011-08-29
EP2894226A1 (en) 2015-07-15
CN102272319B (en) 2014-08-27
EP2382321A1 (en) 2011-11-02
EP2382321A4 (en) 2012-12-19
CA2749093A1 (en) 2010-07-15
US10787694B2 (en) 2020-09-29
JP2012514473A (en) 2012-06-28
CN102272319A (en) 2011-12-07
JP5818688B2 (en) 2015-11-18
US8859205B2 (en) 2014-10-14
WO2010080910A1 (en) 2010-07-15
US20140377767A1 (en) 2014-12-25

Similar Documents

Publication Publication Date Title
SG10201500705YA (en) Methods and compositions for improving efficiency of nucleic acids amplification reactions
GB201209132D0 (en) Compositions and methods for targeted nucleic acid sequence selection and amplification
GB0921264D0 (en) Method for amplification of target nucleic acid
GB0910302D0 (en) Nucleic acid amplification
SG11201401628WA (en) Compositions and methods for directional nucleic acid amplification and sequencing
GB2470672B (en) Methods of RNA amplification in the presence of DNA
EP2462230A4 (en) Methods and compositions for targeted gene modification
EP2431465A4 (en) Method for synthesis of double-stranded dna corresponding to rna, and method for amplification of the dna
IL215462A0 (en) Multi-primer amplification method for barcoding of target nucleic acids
IL217370A0 (en) Novel nucleic acid prodrugs and methods of use thereof
IL208036A0 (en) Compositions and methods for analysis of nucleic acid molecules during amplification reactions
PL2304054T3 (en) Isothermal nucleic acid amplification
EP2373804A4 (en) Compositions for improving gene amplification
GB0814570D0 (en) Isolation of nucleic acid
EP2528932A4 (en) Methods and compositions for sequence-specific purification and multiplex analysis of nucleic acids
IL214326A0 (en) Method of amplification of gc-rich dna templates
EP2382330A4 (en) Cross priming amplification of target nucleic acids
ZA201102195B (en) Methods and compositions for isolating nucleic acid
IL214195A0 (en) Methods for amplifying hepatitis c virus nucleic acids
EP2488664A4 (en) Methods and compositions for amplifying target sequences from nucleic acid samples
GB0812862D0 (en) Nucleic acid amplification
EP2334814A4 (en) Methods and compositions for direct detection of dna damage
GB0803109D0 (en) Method of nucleic acid recombination
EP2195453A4 (en) Method of amplifying nucleic acid
GB0807321D0 (en) Analysis of nucleic acids